PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales and Scotland, PrEP is available through NHS sexual health clinics.It is also...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

  • PrEP use taking off in Thailand and Vietnam

    Pre-exposure prophylaxis (PrEP) use is accelerating among men who have sex with men and transgender women in two south-east Asian countries where it is receiving funding and government support, the 22nd International AIDS Conference (AIDS 2018) ...

    13 August 2018 | Gus Cairns
  • PrEP spreads across Africa – slowly

    This year, 2018, will be the year that a really significant number of people in Africa started HIV pre-exposure prophylaxis (PrEP), the 22nd International AIDS Conference (AIDS 2018) in Amsterdam heard last week. PrEP was probably the dominant ...

    06 August 2018 | Gus Cairns
  • Increase in STIs in PrEP users is concentrated in a minority of men and is partly due to more STI screening

    There were significant increases in bacterial sexually transmitted infections (STIs) in gay and bisexual men taking pre-exposure prophylaxis (PrEP) for the first time in Victoria, Australia, but infections were concentrated in a subset of PrEP users – 13% of ...

    01 August 2018 | Roger Pebody
  • Most adolescent PrEP users in US are young women

    Only 1.5% of people who have used pre-exposure prophylaxis (PrEP) in the United States are aged 17 or younger, and more than 80% of them are girls and young women, according to estimates from Gilead Sciences ...

    31 July 2018 | Liz Highleyman
  • HIV elimination in gay men: what is working?

    Substantial decreases in HIV diagnoses in key cities show the way to elimination of new HIV diagnoses in gay men, a workshop at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam heard on Tuesday. Public health officials, clinicians ...

    26 July 2018 | Lisa Power
  • PrEP use linked to fewer new HIV infections in US states

    As pre-exposure prophylaxis (PrEP) use continues to grow, epidemiological evidence is starting to show an association between increases in PrEP uptake and declines in new infections. A new analysis presented this week at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam ...

    26 July 2018 | Liz Highleyman
  • Unprecedented hepatitis C infection rates seen in gay men in Amsterdam PrEP programme

    Regular hepatitis C testing among the HIV-negative gay men and other men who have sex with men (MSM) participating in the Amsterdam pre-exposure prophylaxis (PrEP) demonstration project (AmPrEP) has revealed infection rates via sex previously only ...

    25 July 2018 | Gus Cairns
  • PrEP does not lower feminising hormone level in transgender women

    Using Truvada (tenofovir DF/emtricitabine) for HIV prevention does not lower levels of feminising hormones, offering reassurance for transgender women who are concerned about drug interactions, according to a presentation at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.  Tenofovir levels in ...

    25 July 2018 | Liz Highleyman
  • On-demand dosing as effective as daily dosing in first year of French PrEP study

    There have been no new HIV infections in the 1628 people taking part in a demonstration study of pre-exposure prophylaxis (PrEP) in France. Over half of participants chose to use on-demand dosing for PrEP, with the rest opting ...

    24 July 2018 | Roger Pebody
  • PrEP@Home pilot shows monitoring PrEP without clinic visit is feasible and acceptable

    A pilot project, PrEP@Home, reduced clinic visits to one a year and demonstrated that men who have sex with men in three US cities were able to carry out all necessary sampling for tests at home, ...

    12 July 2018 | Keith Alcorn
More news

PrEP news selected from other sources

  • Privilege and Profit Corrupt the PrEP Access Debate

    If most folks are getting their PrEP for free, then who cares what Gilead charges? Peter Staley explains why ALL of us should care.

    9 hours ago | Poz
  • People taking HIV-prevention pill may get more primary care

    When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.

    10 hours ago | Reuters
  • Declining HIV numbers bolstered by new prevention drug but more data needed

    Changes to HIV medications are on the horizon just a few months after New Zealand became one of the first countries to publicly fund a "revolutionary" prevention drug. National regulator Pharmac has begun a three-week tender process for a selection of antiretroviral treatments (ARTs) to be provided to hospitals and community pharmacies around the country.

    13 August 2018 | Stuff.nz
  • Why Do Some Gay and Bi Men Stigmatize PrEP Users?

    A focus-group-based study parsed men’s attitudes about pre-exposure prophylaxis.

    10 August 2018 | Poz
  • PrEP scales up, HIV incidence declines

    As use of PrEP continues to grow, epidemiological evidence is starting to show a link between increased use and declines in new HIV infections.

    09 August 2018 | BETA blog
  • New Zealand: Pharmac widens access to 'revolutionary' HIV-prevention drug

    Hundreds of prescriptions for a "revolutionary" HIV-prevention drug have been approved in the first few months of it being more widely available. Pharmac expanded access to Truvada in March. In the first three months, 695 people got the medication for the first time, paying $5 for a three-month prescription.

    08 August 2018 | Newshub
  • Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

    The commercial, aptly titled "I'm on the Pill," is part of a marketing push that has helped turned the use of Truvada for preventing HIV into a $1.3 billion blockbuster, almost 5% of Gilead's annual sales.

    07 August 2018 | Forbes Magazine
  • Thailand brings PrEP to scale

    Thailand is starting to roll out pre-exposure prophylaxis (PrEP) for HIV prevention among key higher-risk groups in high burden provinces, scaling up PrEP pilot projects within the national health system. The announcement was made at the satellite session “Breaking barriers and building bridges toward sustainability of the AIDS response in South-East Asia” during the International AIDS Conference in Amsterdam, Netherlands.

    02 August 2018 | UNAIDS
  • The perception of PrEP as an excuse for promiscuity

    A new study sought to deconstruct the moral debate surrounding biomedical HIV prevention and the complex ways in which PrEP and PrEP users are defined within the gay and bisexual communities. The study examined the stereotypes attributed to PrEP users and how these stereotypes contribute to framing the use of PrEP by some as a social problem. The findings were published in Sociology of Health & Illness.

    02 August 2018 | Medical Xpress
  • Iowa's TelePrEP Program is helping patients afford HIV prevention

    The TelePrEP program uses video conferencing between patients and health care providers. Doctors or pharmacist will talk to their patients, help them find insurance and work with providers so patients don't have to worry about the cost.

    01 August 2018 | KCRG
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.